Cargando…
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
BACKGROUND: To review our experience using methotrexate as a single long-term immunosuppressant (IS) therapy in neuromyelitis optica/neuromyelitis optica spectrum disorders (NMO/NMOSD). METHODS: We performed a retrospective chart review of all patients with a diagnosis of NMO/NMOSD, supported by a p...
Autores principales: | Ramanathan, Ramnath Santosh, Malhotra, Konark, Scott, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985587/ https://www.ncbi.nlm.nih.gov/pubmed/24628894 http://dx.doi.org/10.1186/1471-2377-14-51 |
Ejemplares similares
-
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021) -
Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020) -
Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015) -
Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)